Sign inJoin waitlistJoin the waitlist

Roger Strair

Director, Blood &Amp · Cooper Medical School of Rowan University/Cooper University Hospital

Credentials: · · · · · ·

History

Blood &amp · Cooper Medical School of Rowan University/Cooper University Hospital
Present

Hematology and Medical Oncology
1984–1987
Internal Medicine
1981–1984
Albert Einstein College of Medicine
1977–1981

Research

Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Clinical Cancer Research · 2016 · 316 citations
Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma
Journal of Clinical Oncology · 2007 · 199 citations
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies
Clinical Cancer Research · 2008 · 198 citations

Dale Schaar
15 papers · 2 as a fellow
Lauri Goodell
10 papers · 1 as a fellow
DS
David Shafritz
8 papers
Dennis Cooper
7 papers
JA
Joseph Aisner
6 papers
MG
Mecide Gharibo
6 papers
Vimal Patel
5 papers · 1 as a fellow
MK
Mercy Kuriyan
4 papers
AR
Arnold Rubin
3 papers
Brian Smith
3 papers
KD
Kevin David
3 papers
Mohamed Dabaja
3 papers

Grants

Phase i Trial of 12 0 Tetradecanoylphorbol 13 Acetate
National Cancer Institute · R03
Contact PI · $151.3K · Univ of Med/Dent Nj-r w Johnson Med Sch
2000–2004
Detection of Viral Transactivators in Primary Cells
National Cancer Institute · R01
Contact PI · $481.3K · Yale University
1991–1995
Isolation of a Human e1a-Like Factor
National Cancer Institute · R29
Contact PI · $501.4K · Yale University
1989–1993

Clinical trials

A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
Principal investigator · Recruiting · Early phase 1
Roger Strair
2025–2026
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
Principal investigator · Completed · Phase 2
Rutgers, The State University of New Jersey
2020–2022
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Principal investigator · Terminated · Early phase 1
Rutgers, The State University of New Jersey
2020–2022
Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
Principal investigator · Terminated
Rutgers, The State University of New Jersey
2017–2018